Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC

  • H. A. Yu
  • , C. Baik
  • , D. W. Kim
  • , M. L. Johnson
  • , H. Hayashi
  • , M. Nishio
  • , J. C.H. Yang
  • , W. C. Su
  • , K. A. Gold
  • , M. Koczywas
  • , E. F. Smit
  • , C. E. Steuer
  • , E. Felip
  • , H. Murakami
  • , S. W. Kim
  • , X. Su
  • , S. Sato
  • , P. D. Fan
  • , M. Fujimura
  • , Y. Tanaka
    • P. Patel, D. W. Sternberg, D. Sellami, P. A. Jänne

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science